19
1
49
7
8
a
1b
1d
18
79
34
1d
2 29
1d
25
34
Brendan J Kelly, MD, MS
8cAssistant Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
7
5f
Department: Medicine
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
5a
4
3
3
1d
5a
731 Blockley Hall
Philadelphia, PA 19104
26
Philadelphia, PA 19104
35
f
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 7 AB 20 (History and Science) c
3c Harvard College, Harvard University, 2002.
21 7 MD c
50 College of Physicians and Surgeons, Columbia University, 2007.
21 9 MSCE 21 (Genetic Epidemiology) c
67 Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2013.
c
3
27
21 7 AB 20 (History and Science) c
3c Harvard College, Harvard University, 2002.
21 7 MD c
50 College of Physicians and Surgeons, Columbia University, 2007.
21 9 MSCE 21 (Genetic Epidemiology) c
67 Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2013.
c
Links
c4 Search PubMed for articles
d
5
3
3
8d
Permanent linkc4 Search PubMed for articles
d
2 29
21
1e
1d
24
7
29
27
23
f5 Lucky CW, Medernach RL, Kelly BJ, Kwon JH, Woodworth MH.: Microbiome Therapeutics for Clostridioides difficile Infection. Infect Dis Clin North Am 39(4): 663-683, Dec 2025.
13c Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden L, Cressman L, Huang E, Patel A, Lautenbach E, Pegues DA, Kelly BJ.: Screening and targeted prophylaxis for Clostridioides difficile infection. Clin Microbiol Infect 31(11): 1907-1913, Nov 2025.
12a Laurel Redding, Scott G. Daniel, Joseph D. Zackular, Maho Okumura, Stephen D. Cole, Kyle Bittinger, Brendan J. Kelly: Amplicon-Based Sequencing is Able to Accurately Detect Clostridioides Difficile. SSRN [preprint] July 2025.
17d Ziegler MJ, Loughrey S, Bekele S, Huang E, Tolomeo P, David MZ, Lautenbach E, Glaser LJ, Kelly BJ.: Comparative performance of sponge versus flocked swabs for culture-based and metagenomic detection of microbial contamination in the healthcare environment. Infect Control Hosp Epidemiol 46(8): 1-7, May 2025.
160 Sherrie Xie, Leigh Cressman, Matthew J. Ziegler, Brendan J. Kelly: Impact of time post-hospitalization on carbapenem-resistance among Enterobacterales infections. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 (Vienna, Austria) April 2025.
146 Alyssa Mezochow, Emilia Wilkins, Leigh Cressman, Brendan J. Kelly: Lung pathogens persist in the gut microbiome during critical illness. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 (Vienna, Austria) April 2025.
a3 Kelly BJ, Kwon JH, Woodworth MH.: Reply to Olle et al. J Infect Dis 231(2): 545, Feb 2025.
173 Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden C, Cressman L, Huang E, Patel A, Lautenbach E, Kelly BJ: Screening and targeted prophylaxis for Clostridioides difficile infection: STOP-CDI. Infectious Diseases Society of America, IDWeek. Oral Presentation; 2024 Oct; Los Angeles, CA. October 2024.
c3 Kelly BJ, Kwon JH, Woodworth MH.: Escape Velocity-the Launch of Microbiome Therapies. J Infect Dis 230(30): 2-4, Jul 2024.
2c
7
1d
1f
Selected Publications
165 Monica Wei, Matthew J. Ziegler, Pam Tolomeo, Laura Cowden, Brendan J. Kelly: k-mer sketch profiles identify suspected multidrug-resistant organism transmission events. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026 (Munich, Germany) April 2026.f5 Lucky CW, Medernach RL, Kelly BJ, Kwon JH, Woodworth MH.: Microbiome Therapeutics for Clostridioides difficile Infection. Infect Dis Clin North Am 39(4): 663-683, Dec 2025.
13c Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden L, Cressman L, Huang E, Patel A, Lautenbach E, Pegues DA, Kelly BJ.: Screening and targeted prophylaxis for Clostridioides difficile infection. Clin Microbiol Infect 31(11): 1907-1913, Nov 2025.
12a Laurel Redding, Scott G. Daniel, Joseph D. Zackular, Maho Okumura, Stephen D. Cole, Kyle Bittinger, Brendan J. Kelly: Amplicon-Based Sequencing is Able to Accurately Detect Clostridioides Difficile. SSRN [preprint] July 2025.
17d Ziegler MJ, Loughrey S, Bekele S, Huang E, Tolomeo P, David MZ, Lautenbach E, Glaser LJ, Kelly BJ.: Comparative performance of sponge versus flocked swabs for culture-based and metagenomic detection of microbial contamination in the healthcare environment. Infect Control Hosp Epidemiol 46(8): 1-7, May 2025.
160 Sherrie Xie, Leigh Cressman, Matthew J. Ziegler, Brendan J. Kelly: Impact of time post-hospitalization on carbapenem-resistance among Enterobacterales infections. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 (Vienna, Austria) April 2025.
146 Alyssa Mezochow, Emilia Wilkins, Leigh Cressman, Brendan J. Kelly: Lung pathogens persist in the gut microbiome during critical illness. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 (Vienna, Austria) April 2025.
a3 Kelly BJ, Kwon JH, Woodworth MH.: Reply to Olle et al. J Infect Dis 231(2): 545, Feb 2025.
173 Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden C, Cressman L, Huang E, Patel A, Lautenbach E, Kelly BJ: Screening and targeted prophylaxis for Clostridioides difficile infection: STOP-CDI. Infectious Diseases Society of America, IDWeek. Oral Presentation; 2024 Oct; Los Angeles, CA. October 2024.
c3 Kelly BJ, Kwon JH, Woodworth MH.: Escape Velocity-the Launch of Microbiome Therapies. J Infect Dis 230(30): 2-4, Jul 2024.
2c